Objectives: Healthcare facilities internationally have grown outpatient parenteral antibiotic administration services for the last few decades. The literature contains publications from dozens of countries describing systematized processes with specialist oversight and their levels of service provision and outcomes. Such descriptions are absent in the majority of Asian countries. We sought to elucidate the extent and nature of outpatient parenteral antibiotic therapy (OPAT) in Asia and to consider the ramifications and opportunities for improvement Methods: Utilizing colleagues and their personal networks, we surveyed healthcare facilities across 17 countries in Asia to ascertain the current means (if any) of providing OPAT. In that survey we also sought to explore the capacity and interest of these facilities in developing systematized OPAT services.
Introduction
Outpatient parenteral antibiotic therapy (OPAT) is a system of outpatient care in which parenteral antibiotics are provided in a noninpatient setting, without the need for overnight stay in hospital. The IDSA defines OPAT as 'the provision of parenteral antimicrobial therapy in at least two doses on different days without intervening hospitalization'. OPAT may be provided in infusion clinics or stepdown accommodation by a specialized nurse, or at home where it may alternatively be administered by patients themselves or by a caregiver. [1] [2] [3] We question the value of the IDSA definition as it focuses solely on the absence of hospitalization and implies appropriate health service provision, whereas several other factors are key to a quality OPAT service. A poorly designed service may encourage unnecessary or suboptimal care and standards.
A comprehensive OPAT service should provide specific medical and nursing expertise and a broad antibiotic formulary. It should provide patient-centric, holistic care meeting all needs including blood monitoring, wound management and following the condition, making adjustments to ensure optimal care of the primary illness, comorbidities and emerging issues including both medical and social complications. Such specialized purpose-designed services have staff qualified in antibiotic choice (including dose, duration and route) and line care, as well as an outcomes registry to V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
facilitate service oversight, trends, adverse events, readmissions and the like.
A less comprehensive OPAT could simply involve an infusion service where patients attend for once-daily therapy without specific medical oversight, clinical or nursing expertise, or other benefits (Table 1) .
First described in 1974, OPAT is now practised commonly in Canada and the UK, as well as in some other countries in Europe, South America and the Asia Pacific in various forms. [4] [5] [6] [7] [8] In Australia, OPAT was first offered as part of the hospitalin-the-home (HITH) programme initiated over 20 years ago, and has since been successfully adopted and implemented by numerous centres across that country and New Zealand. [9] [10] [11] [12] OPAT services were first introduced to Singapore in 2002, and since then most of Singapore's public hospitals have established OPAT programmes. Care delivery models in these institutions are similar, whereby patients attend specific outpatient centres to receive care from a specialized team (including medical, nursing and pharmacy). Many patients on 24 h infuser devices opt for s-OPAT (self-or carer-provided OPAT) so that daily attendance is not required. 7, [13] [14] [15] Home-visit OPAT models are also available, but are normally reserved for patients with impaired mobility or for those who would otherwise require ambulance services for transport to hospital. For these patients, antibiotics are administered by community nurses who visit daily.
The opportunities for high-quality and consistent care are surely more challenging in the infusion service model where they are colocated with an emergency department or outpatient clinic. Predictably there is no continuity of medical and nursing staff, no outcomes registry and likely no specialist input into antibiotic prescription.
Australia, New Zealand and Singapore remain the only countries in the Asia Pacific to have implemented such comprehensive OPAT services nationally. The literature identifies Japan as the only other country to undertake OPAT in a healthcare institution in a systematic way. 16 We sought to explore the extent to which outpatient parenteral antibiotics are provided in Asia via a short survey.
Methods
In June 2016 a simple electronic survey (SurveyMonkey Inc., Palo Alto, CA, USA) was piloted to ensure the quality of the questions and to test that it could be undertaken by participants whose English skills may be limited. See summary in Figure 1 and full version in the Supplementary data available at JAC Online. Professional contacts of the authors, working in infectious diseases or internal medicine, were the main recipients of requests to undertake the survey. Secondary contacts were sought in an attempt to reach reasonable distribution across most Asian countries. Nurses, pharmacists and hospital administrators with a knowledge of their hospital services with regards to outpatient parenteral antibiotic services were also eligible to provide a response. The opening question of the survey asked if they had adequate knowledge to complete the survey. A negative response led to an immediate exit from the survey. The full survey required less than 5 minutes to complete.
After 1 month the survey was closed. We needed just one response per hospital so duplicates and incomplete responses were removed, as were those declaring inadequate knowledge. Where duplicate responses from one institution gave conflicting information the authors amalgamated into one response by taking an average or most common answer for each question.
Ethics
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Results
After exclusions the survey contained responses from 171 different institutions in 17 Asian countries: Bangladesh (4), Brunei (4), Cambodia (3), China (13), Hong Kong (2), India (29), Indonesia (21), Japan (36), Malaysia (9), Mongolia (1), Myanmar (7), Philippines (6), Singapore (9), Sri Lanka (5), Taiwan (5), Thailand (16) and Vietnam (1). Most were university or tertiary referral centres (124) with 62% government funded and the remainder private. Another 35 institutions were also acute hospitals, 5 non-acute and 7 outpatient-only services. There were 39 (23%) hospitals with over 1000 beds in the survey, 53 (31%) with 500-1000 beds, 50 (29%) with 200-500 beds, Fisher et al.
21 (12%) with 1-200 beds and 8 (5%) with 0 inpatient beds. Most respondents were doctors (89%) and nurses (8%). We found just 11 institutions claiming a comprehensive OPAT service: Singapore (6) and one in each of Malaysia, Hong Kong, India, Indonesia and Japan. Infusion services were described by 36 institutions in 9 countries. Outpatient parenteral antibiotics were provided by individual clinic administration in 47 inpatient institutions in 10 countries and 3 outpatient institutions in 3 countries, while 74 institutions in 16 countries reported that they would not administer parenteral antibiotics to outpatients.
Of the 11 'comprehensive OPATs', 7 were university or tertiary referral centres and 9 had more than 500 inpatient beds. Seven saw more than 100 patients per year (three of which saw more than 300, all in Singapore). Five services had been active for more than 5 years (all in Singapore) and two had only commenced in the last 12 months. Continuous infuser devices were commonly used in all Singaporean centres plus the Japanese and Malaysian centres. Nine of the services were run by infectious diseases physicians while others were managed by oncologists or by the referring doctor.
Eight services maintained a database for the purposes of tracking service utilization (7), monitoring patient outcomes (7) and benchmarking (2) . In only three services was the database electronic.
Where we defined an infusion service (36 respondents) as a non-specialized facility without specific oversight their locations were most commonly in the emergency department (18), followed by a specified outpatient clinic (10), inpatient area (2) while other sites varied (6). They were common in university and tertiary referral centres (29) and especially in India (10), China (8) and Thailand (7). Ten hospitals had more than 1000 beds and 13 serviced more than 300 patients per year. At least 50% have functioned for more than 5 years; however, 10 had plans to formalize these services into the more comprehensive OPAT model.
The 50 respondents (47 from inpatient facilities and 3 from outpatient-only facilities) who stated that parenteral antibiotics were provided by individual clinicians in their clinics represented 11 countries, including Japan (28), India (7) and China (4). Respondents had difficulty quantifying the number of patients receiving treatment this way with numbers ranging from less than 20 to over Select one of the following that best describes the manner in which intravenous antibiotics are administered to outpatients
Our OPAT in Asia JAC 300, but many were unsure. The size of the facilities doing this varied considerably from no inpatient beds to more than 1000. Seventy-four institutions stated they gave no parenteral antibiotics to outpatients. This response was received from all countries except Singapore, including Indonesia (91% of Indonesian respondents), Malaysia (89%), Sri Lanka (100%), Brunei (100%), Myanmar (57%), Bangladesh (50%), Taiwan (40%), Philippines (40%), Thailand (37%), India (32%) and Japan (17%).
There were many reasons suggested as to why an institution would not have a comprehensive OPAT including the points listed below (with the number of responses and percentage of the total number of respondents who answered this question):
• We have never seen the need (11, 7.9%).
• We don't believe patients would use the service (14, 10.1%).
• It is unlikely that resources, including space, would be allocated to develop this type of service (62, 44.6%).
• We don't have a team to drive the service (32, 23%).
• We could do it, but we don't know how (39, 28.1%).
• Government and insurance restrictions (7, 5%).
Discussion
This survey supported our hypothesis that parenteral antibiotics are commonly provided in an outpatient setting, but that the delivery is likely to be performed with suboptimal oversight. OPAT, according to the standard definition, is provided in at least 13 of the 17 countries from where we received responses in Asia. Comprehensive OPAT was rare outside of Singapore. It is possible that such services were missed by our recruiting methods; however, they are unknown to the authors and their colleagues involved in this survey, and do not appear in the available literature. This illustrates a weakness of our study in that the survey could not be a statistical or targeted sampling of Asian healthcare facilities as the methodology involved e-mail recruitment via personal clinical networks.
The lack of a systematic approach to OPAT in most countries prevents stakeholders from understanding the appropriateness of antibiotic usage. This is contrary to worldwide efforts targeting antibiotic use in the struggle against emerging MDR organisms. Furthermore, individual patient care risks a lack of oversight, coordination and outcomes monitoring in such infusion services.
This survey provides a qualitative view of OPAT in Asia. We could not validate the responses although there was reasonable concordance with our expectations, namely that comprehensive OPATs are absent or perhaps very sporadic through most of Asia yet other formats are frequently used, highlighting the demand.
The need for comprehensive OPAT programmes
A key goal of OPAT is provision of care that is at least as effective as inpatient care. An OPAT bundle, including maintenance of an outcomes registry, has recently been proposed to optimize outcomes. 17 An analysis of all enrolled OPAT cases over 6 years in two public hospitals in Singapore found that 84% of patients completed treatment as planned and the rate of readmissions due to clinical deterioration, or OPAT-related complications or adverse events, was 10.2%. 13 Most readmissions were, however, due to another, coinciding comorbidity and were not primarily OPAT related. All readmissions occurred in a timely and coordinated manner, without significant setback.
Patients describe greater satisfaction with therapy when treated outside of hospital due to increased mobility and less restriction of activity, which translates to improved quality of life and increased productivity. 18, 19 When surveyed, almost all OPAT patients in the UK and Singapore responded that they would choose to undergo OPAT again as it allowed them to resume daily activities. 15, 20, 21 In a health-related quality of life assessment of OPAT patients in Canada, significant improvements were achieved in terms of physical function, bodily pain and emotional problems when patients moved from the hospital to a home setting. 22 This is particularly important in Asia, where patients often need to return to work or resume their role as primary providers at home due to a lack of other social supports.
The role of OPAT in antimicrobial stewardship programmes has been recognized by major practice guidelines from the UK. 1, 23 Decentralized, new or small OPAT services devoid of the benefits of structure (Table 1 ) will necessarily not be using continuousinfusion devices (and therefore the expanded formulary which accompanies these) nor skilled doctors, nurses and pharmacists who facilitate antibiotic infusions. These services will invariably be limited to once-daily medications of especially ceftriaxone and possibly ertapenem. 16 If the patient were in hospital or in a specialized OPAT programme they would have access to a much greater choice including narrower-spectrum antibiotics such as penicillins and first-and fourth-generation cephalosporins.
OPAT has well-documented strength in its potential to address bed shortages and therefore best utilize hospital inpatient resources; in fact this is a feature of publications reporting outcomes. In the only matched-comparison cost analysis of OPAT in Asia, OPAT was found to cost 40% less than inpatient-only care in terms of cost per day, although length of treatment in OPAT was prolonged. Cost analysis considerations typically face difficulties in factoring in a fully holistic assessment, which ideally would include hospital resource diversion, patient productivity and impact on caregivers.
The risk of infection related to home care appears to be much less than the risk of nosocomial infections, and the chances of acquiring an antimicrobial-resistant organism from the home environment are likewise lower. 24 It is not possible to maintain data in the absence of a consolidated system of care. Data such as those outlined in Table 1 enable optimal antibiotic utilization, oversight of service uptake, outcomes and advocacy to develop the programme. Drug stability over 24 h in an infuser device is not available above 25 C and it is possible that OPAT patients in many tropical countries expose their infusions to higher temperatures. This is another example of why outcomes data in a system-based OPAT is critical for oversight.
Recommended standards for administering outpatient parenteral antibiotics
Ad hoc prescription and administration by multiple providers within the same institution should be avoided. Such services should be combined, guided by a multidisciplinary administration including a clinician with medical expertise in the field, nursing administration, finance, operations and pharmacy. This group can establish the Fisher et al.
many required standard operating procedures, a site for the service and clinical work flows. Financial matters will need consideration and will be based on local funding models and drivers, specific to that country, region or institution.
An outcomes database to include factors outlined in Table 1 should be established to optimize the service and ensure its sustainability.
Possible challenges and solutions for initiating comprehensive OPAT programmes in Asia
Our survey highlighted a diversity of barriers to initiating a comprehensive OPAT service, with resource allocation perceived as the most significant. OPAT establishment could initially be an additional burden on individual health service providers. Furthermore, there may be a financial disincentive to patients in some countries where moving from inpatient to outpatient care removes access to subsidies, insurance and other funding sources. Local OPAT champions need to understand funding systems and drivers of change. Innovation and advocacy are often required to build community and government support for OPAT. Options have included creation of 'virtual inpatient wards', shifting costs where there are multiple health funders or capped government subsidies to ease excess demand on hospital beds.
There may be a lack of staff with the knowledge, skills and motivation to develop OPAT in hospitals in Asia. Infectious disease specialists are scarce in most countries and may already have heavy clinical workloads. The use of trained infusion nurses likewise will need to be developed. Educational and training initiatives will be helpful, partnering with international colleagues, especially within the region, to develop skills. Best-practice sharing and endorsement from experienced experts and institutions with wellestablished OPAT programmes may be influential in encouraging uptake and implementation.
There may be reasonable concern over the effectiveness of infusions due to the availability of drug stability data (especially domestic or generic antibiotics). Providing infusions through a centralized service allows an overview of outcomes and therefore of clinical failure rates. It also is an opportunity to advocate to research groups and communicate the need for particular data.
There may be a pre-existing mindset whereby patients prefer to be hospitalized than to receive care at home. Bed shortages in hospitals make patients anxious about being discharged from hospital as they worry that a bed would not be available if readmission is required for treatment. Further, there is often a lack of caregivers to care for elderly patients once they are discharged on OPAT.
Conclusions
Comprehensive OPAT programmes have been proven internationally to be safe, effective, efficient and popular, but are uncommon in most of Asia. The fact that unstructured OPAT systems exists confirms the demand for parenteral antibiotics to be given to outpatients across Asia. Unfortunately, the vast majority of existing services are tagged onto existing outpatient services such as emergency departments and clinics. This prevents the benefits (Table 1 ) of a comprehensive service and illustrates the opportunity being missed. New OPAT services need to adapt to local funding models, clinical services and sociocultural nuances, engaging closely with all stakeholders to ensure buy-in and sustainability. As a medical community we should work to facilitate the development of this superior model of care despite the difficulties anticipated.
As the inevitable barriers present we should not lose track of the fact that OPAT care is the best model and 'the right thing to do'. Fostering strategic partnerships with stakeholders at all levels will be crucial to ensuring its success in Asian countries.
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